Status:
RECRUITING
A Patient-Centric Platform Trial for Precision Oncology
Lead Sponsor:
xCures
Collaborating Sponsors:
Cancer Commons
Musella Foundation for Brain Tumor Research and Information, Inc.
Conditions:
Oncology
Eligibility:
All Genders
Brief Summary
XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and asso...
Detailed Description
XCELSIOR is patient-centric study for the registration of cancer patients, operations of a virtual tumor board, insight capture in clinical decision making, and collection of longitudinal, observation...
Eligibility Criteria
Inclusion
- Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
- Patients with any performance status, comorbidity or disease severity are eligible
- Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)
Exclusion
- Patients must be a resident of or receiving care within the United States or US territories.
Key Trial Info
Start Date :
February 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03793088
Start Date
February 7 2019
End Date
January 1 2026
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Commons
Los Altos, California, United States, 94022